MedBright AI Welcomes Two Healthcare Specialists to its Board and Introduces a New Share Class

VANCOUVER, British Columbia – In a noteworthy advancement for MedBright AI Investments Inc. (hereafter referred to as 'MedBright' or the 'Company'), two distinguished US healthcare experts, Dr. Jaime Gerber and Dr. Konita Wilks, have joined the Company's Board of Directors. This strategic move aims to leverage their extensive industry experience to guide the Company's direction in the healthcare investment landscape.

Election of New Board Members

The addition of these two board members is a significant enhancement for MedBright's governance and strategic planning. Dr. Gerber, with a deep-seated career in clinical research, and Dr. Wilks, known for her progressive work in healthcare administration, bring a wealth of knowledge and insights to the table. Their expertise is expected to make a substantial contribution to MedBright's commitment to innovation and growth in the healthcare investment domain.

Approval of New Share Class

In tandem with the expansion of its board, MedBright has also announced the approval of a new share class. This development is anticipated to provide investors with more flexibility and potentially broaden the Company's investor base. The specifics of the new share class, including rights and privileges, will be detailed in upcoming communications to shareholders and the market at large.

The market has responded positively to these announcements, reflecting in MedBright's stock performance across various exchanges, including OTC:MBAIF, underscoring investor confidence in the Company's strategic direction.

MedBright, Healthcare, Investment